Natco Pharma soars as its arm acquires 49% stake in PT NATCO Lotus Farma
Natco Pharma is currently trading at Rs. 834.80, up by 21.30 points or 2.62% from its previous closing of Rs. 813.50 on the BSE.
The scrip opened at Rs. 811.75 and has touched a high and low of Rs. 840.70 and Rs. 808.00 respectively. So far 49989 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1340.45 on 07-Feb-2025 and a 52 week low of Rs. 660.05 on 07-Apr-2025.
Last one week high and low of the scrip stood at Rs. 840.70 and Rs. 808.00 respectively. The current market cap of the company is Rs. 14928.81 crore.
The promoters holding in the company stood at 49.48%, while Institutions and Non-Institutions held 20.54% and 29.97% respectively.
Natco Pharma’s wholly-owned subsidiary (WOS) -- NATCO Pharma Asia has acquired 49% of shareholding in PT NATCO Lotus Farma from PT Lotus Farma Indonesia. The company already owns 51% of PT NATCO Lotus Farma. Post this acquisition, the company along with its WOS wholly-owns 100% of PT NATCO Lotus Farma.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
.jpg)
